Molecular basis of dopamine replacement therapy and its side effects in Parkinson’s disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Molecular basis of dopamine replacement therapy and its side effects in Parkinson’s disease

Published:2018-03-07 Issue:1 Volume:373 Page:111-135
ISSN:0302-766X
Container-title:Cell and Tissue Research
language:en
Short-container-title:Cell Tissue Res

Author:

You Hana,Mariani Louise-Laure,Mangone Graziella,Le Febvre de Nailly Delphine,Charbonnier-Beaupel Fanny,Corvol Jean-Christophe

Funder

Investissements d’Avenir

Innovative Medicines Initiative Joint Undertaking

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Link

http://link.springer.com/article/10.1007/s00441-018-2813-2/fulltext.html

Reference314 articles.

1. Agid Y (2001) Levodopa. Is toxicity a myth? 1998. Neurology 57:S46–S51

2. Ahlskog JE (2003) Slowing Parkinson’s disease progression: recent dopamine agonist trials. Neurology 60:381–389

3. Ahmed MR, Bychkov E, Gurevich VV et al (2008) Altered expression and subcellular distribution of GRK subtypes in the dopamine-depleted rat basal ganglia is not normalized by l-DOPA treatment. J Neurochem 104:1622–1636

4. Alcacer C, Santini E, Valjent E et al (2012) Gα(olf) mutation allows parsing the role of cAMP-dependent and extracellular signal-regulated kinase-dependent signaling in L-3,4-dihydroxyphenylalanine-induced dyskinesia. J Neurosci 32:5900–5910

5. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, fourth edition, text revision (DSM-IV-TR), 4th edn. American Psychiatric Association, Arlington

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond insulin: The Intriguing role of GLP-1 in Parkinson's disease;European Journal of Pharmacology;2024-11

2. Levodopa-induced dyskinesia in Parkinson's disease: Insights from cross-cohort prognostic analysis using machine learning;Parkinsonism & Related Disorders;2024-09

3. The PM20D1-NADA pathway protects against Parkinson’s disease;Cell Death & Differentiation;2024-08-22

4. Consistent abnormal activity in the putamen by dopamine modulation in Parkinson’s disease: A resting-state neuroimaging meta-analysis;Brain Research Bulletin;2024-05

5. Effects and Mechanisms of Exercise on Brain-Derived Neurotrophic Factor (BDNF) Levels and Clinical Outcomes in People with Parkinson’s Disease: A Systematic Review and Meta-Analysis;Brain Sciences;2024-02-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3